mapk
Entity, reached from Hormuz.
- Evidence
- 32 documents · 12 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 15 Mar 2026, last seen 8 Oct 2026
- Measured
- 3% of mentions say something specific about it; the rest only name it
- As of
- 10 Oct 2026
Where this comes from
- bioRxiv Cancer Biology · 2026-10-06 · p38α MAPK integrates opposing oncogenic APC/β-catenin/TCF and GUCY2C tumor-suppressor axes in colorectal cancer (opens the source in a new tab)
- bioRxiv Cancer Biology · 2026-10-06 · Binding kinetics enable tumor-selective MAPK and growth suppression by a Type 1 RAF Inhibitor (opens the source in a new tab)
- bioRxiv Cancer Biology · 2026-09-28 · Pathway-wide base editing charts chemical-genetic interactions in MAPK signaling (opens the source in a new tab)
- GEN · 2026-09-18 · Kidney Organoids Reveal Inflammatory Drivers of Diabetic Kidney Disease (opens the source in a new tab)
- bioRxiv Cancer Biology · 2026-09-15 · HrasG12V induces follicular thyroid cancer with attenuated MAPK activation and increased latency compared to KrasG12D (opens the source in a new tab)
- bioRxiv · 2026-09-15 · Hras G12V induces follicular thyroid cancer with attenuated MAPK activation and increased latency compared to Kras G12D. (opens the source in a new tab)
Links from here: not yet read.
What is claimed about it
Situations it is named in
Who it moves with
- co-mentioned with kras (14 documents)seen together
- co-mentioned with pi3k (14 documents)seen together
- co-mentioned with colorectal cancer (13 documents)seen together
- co-mentioned with nuclear (9 documents)seen together
- co-mentioned with egfr (8 documents)seen together